The surface glycoprotein, glypican-3 (GPC3) is overexpressed in more than 70% of HCC tumors and functions as a regulator of both Yap and Wnt signaling pathways [207,208,209]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.